These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4072436)

  • 21. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
    Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
    Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
    Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
    J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of 5-HT receptors in the development and expression of methamphetamine-induced behavioral sensitization: 5-HT receptor channel and binding study.
    Yoo JH; Cho JH; Yu HS; Lee KW; Lee BH; Jeong SM; Nah SY; Kim HC; Lee SY; Jang CG
    J Neurochem; 2006 Nov; 99(3):976-88. PubMed ID: 16942594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ginsenosides attenuate methamphetamine-induced behavioral side effects in mice via activation of adenosine A2A receptors: possible involvements of the striatal reduction in AP-1 DNA binding activity and proenkephalin gene expression.
    Shin EJ; Nabeshima T; Suh HW; Jhoo WK; Oh KW; Lim YK; Kim DS; Choi KH; Kim HC
    Behav Brain Res; 2005 Mar; 158(1):143-57. PubMed ID: 15680202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of repeated administration of bromocriptine on ambulatory activity in mice, and changes in methamphetamine sensitivity in bromocriptine-experienced mice].
    Asami T; Kuribara H; Tadokoro S
    Yakubutsu Seishin Kodo; 1986 Sep; 6(3):309-17. PubMed ID: 3811623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term suppression of methamphetamine-induced c-Fos expression in rat striatum by the injection of c-fos antisense oligodeoxynucleotides absorbed in water-absorbent polymer.
    Semba J; Wakuta M; Suhara T
    Psychiatry Clin Neurosci; 2004 Oct; 58(5):531-5. PubMed ID: 15482585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of dopamine intracerebrally injected by the Valzelli method on methamphetamine-stereotypy and hypermotility].
    Nomura Y; Ashikari S; Naganuma K; Sakuma K; Watanabe M; Kobayashi M
    Yakubutsu Seishin Kodo; 1982 Jul; 2(1):25-37. PubMed ID: 6892350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of chronic alcohol administration on changes of extracellular dopamine and serotonin concentration induced by methamphetamine--comparison of two different alcohol preference rat lines].
    Nishiguchi M; Kinoshita H; Taniguchi T; Utsumi T; Ouchi H; Minami T; Hishida S
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2002 Dec; 37(6):555-76. PubMed ID: 12607944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of 3H-kainic acid binding in rat cerebral cortex by chronic methamphetamine administration.
    Kashiwabara K; Sato M; Otsuki S
    Biol Psychiatry; 1984 Aug; 19(8):1173-82. PubMed ID: 6093902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of dopamine antagonists on neuronal histamine release in the striatum of rats subjected to acute and chronic treatments with methamphetamine.
    Ito C; Onodera K; Sakurai E; Sato M; Watanabe T
    J Pharmacol Exp Ther; 1996 Oct; 279(1):271-6. PubMed ID: 8859003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein expression profile in the striatum of acute methamphetamine-treated rats.
    Iwazaki T; McGregor IS; Matsumoto I
    Brain Res; 2006 Jun; 1097(1):19-25. PubMed ID: 16729985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein expression profile in the amygdala of rats with methamphetamine-induced behavioral sensitization.
    Iwazaki T; McGregor IS; Matsumoto I
    Neurosci Lett; 2008 Apr; 435(2):113-9. PubMed ID: 18346852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of ambulation-increasing effect produced by repeated administration of methamphetamine in rats and neurochemical changes in catecholaminergic neurons.
    Hayashi T; Kunihara M; Tadokoro S
    Jpn J Pharmacol; 1987 Mar; 43(3):283-90. PubMed ID: 3586416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ["Methamphetamine-stereotypy and hypermotility" in rats chronically treated with reserpine--the effect of intracerebral injection of chlorpromazine].
    Sano H; Totsuka Y; Furuuchi T; Sakai K; Koshikawa N; Shigehara R; Kobayashi M
    Nihon Yakurigaku Zasshi; 1982 Aug; 80(2):113-24. PubMed ID: 6890928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes of behavior and monoamine metabolites in the rat brain after repeated methamphetamine administration: effects of duration of repeated administration.
    Suzuki H; Shishido T; Watanabe Y; Abe H; Shiragata M; Honda K; Horikoshi R; Niwa S
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 Feb; 21(2):359-69. PubMed ID: 9061779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral sensitization to methamphetamine in the rat: an ontogenic study.
    Fujiwara Y; Kazahaya Y; Nakashima M; Sato M; Otsuki S
    Psychopharmacology (Berl); 1987; 91(3):316-9. PubMed ID: 3104953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased in vivo [3H]spiroperidol binding in rat brain after repeated methamphetamine administration.
    Kaneno S; Shimazono Y
    Eur J Pharmacol; 1981 Jun; 72(1):101-5. PubMed ID: 7196335
    [No Abstract]   [Full Text] [Related]  

  • 38. Behavioral hypersensitivity to apomorphine after chronic methamphetamine--intermittent vs. continuous regimen.
    Kashihara K; Sato M; Kazahaya Y; Otsuki S
    Jpn J Psychiatry Neurol; 1986 Mar; 40(1):81-4. PubMed ID: 3773355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancing effects of sound on methamphetamine-induced behavioral aberrations in the rat: a model of relapse of schizophrenia-like symptoms.
    Hada H; Miyamoto K
    Jpn J Psychiatry Neurol; 1990 Sep; 44(3):619-27. PubMed ID: 2074621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization.
    Ujike H; Onoue T; Akiyama K; Hamamura T; Otsuki S
    Psychopharmacology (Berl); 1989; 98(1):89-92. PubMed ID: 2498964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.